Tags: BMRN

Overview: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), from Healthcare sector has been doing well recently. BioMarin Pharmaceutical Inc. has been operating with a total market capitalizations of 14.5B and has reported a price of $83.36 today, highlighting a positive change of 0.23%. The average volume stands at 1305.56 for BioMarin Pharmaceutical Inc.. Performance: The performance week for…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Biotechnology is valued at 15.89 B. The dominant statistics will authorize the investment community to govern the size of BioMarin Pharmaceutical Inc. compared to the sales or total assets figures. Consequently, investors will be able…

THE QUANTITATIVE RELATIONSHIPS BioMarin Pharmaceutical Inc. (BMRN), started its day with an opening price of 91.24 as the company saw a change of 0.20%. The Average Volume of the business is currently 1263.97 with a P/E (price to earnings) ratio of *TBA , while Forward P/E ratio is *TBA. The price to earnings ratio specifies…

Brief Overview BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), from Healthcare sector has been performing well. BioMarin Pharmaceutical Inc. reported a price of 90.27 today, indicating a change of 0.78%. BioMarin Pharmaceutical Inc. has a market capitalization of 15.96 B, with a return on assets (ROA) of -15.10% and an earnings per share (EPS) of -3.41 for the…

Brief Overview BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), from Healthcare sector has been performing well. BioMarin Pharmaceutical Inc. reported a price of 90.35 today, indicating a change of -0.63%. BioMarin Pharmaceutical Inc. has a market capitalization of 16.2 B, with a return on assets (ROA) of -15.10% and an earnings per share (EPS) of -3.41 for the…

With its market value over its outstanding shares, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Biotechnology has a market capitalization valued at Biotechnology. As the outstanding stock of BioMarin Pharmaceutical Inc. NASDAQ:BMRN Biotechnology is bought and sold in the stock market, the current market cap indicates the existing public opinion of the net worth of BioMarin Pharmaceutical Inc. BMRN Biotechnology. The existing figure surely determines…

Brief Overview BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), from Healthcare sector has been performing well. BioMarin Pharmaceutical Inc. reported a price of 90.9 today, indicating a change of 0.43%. BioMarin Pharmaceutical Inc. has a market capitalization of 16.13 B, with a return on assets (ROA) of -15.10% and an earnings per share (EPS) of -3.41 for the…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Biotechnology is valued at 15.58 B. The dominant statistics will authorize the investment community to govern the size of BioMarin Pharmaceutical Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Brief Overview BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), from Healthcare sector has been performing well. BioMarin Pharmaceutical Inc. reported a price of 90.52 today, indicating a change of -1.62%. BioMarin Pharmaceutical Inc. has a market capitalization of 15.91 B, with a return on assets (ROA) of -15.10% and an earnings per share (EPS) of -3.41 for the…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Biotechnology is valued at 15.65 B. The dominant statistics will authorize the investment community to govern the size of BioMarin Pharmaceutical Inc. compared to the sales or total assets figures. Consequently, investors will be able…